Table 1.
Parameter / virus (n) | RSV (318) | Influenza A (591) | Influenza B (289) | SARS-Cov-2 (342) | p |
Demographic data | |||||
Age years | 75.1 (14.3)& | 72.9 (15.3)&& | 75.7 (13.7)&& | 70.8 (15.9)&&& | < 0.001 |
Gender f/m | 135/183 | 261/330 | 135 / 154 | 168 / 174 | 0.301 |
Clinical symptoms | |||||
Cough% | 71& | 68 | 66 | 51&& | < 0.001 |
Headache% | 7*,** | 13 | 18 | 14 | < 0.001 |
Weakness% | 67#,## | 67###,#### | 83 | 78 | < 0.001 |
Enteritis | 10$ | 21 | 20 | 17 | < 0.001 |
Laboratory parameters | |||||
Body temperture °C | 37.31 (0.97)& | 37.54 (1.03)&&,&&& | 37.27 (0.86) | 37.31 (0.93) | < 0.001 |
Leukcocytes n/ul | 10.1 (7.6)*,** | 8.4 (5.8) | 7.4 (6.7) | 8.5 (11.7) | < 0.001 |
C-reactive protein mg/dL | 62.6 (77.1)# | 65.9 (81.0) | 48.8 (68.8)## | 83.4 (83.1)### | < 0.001 |
Lactate dehyrogenase IU/mL | 265 (114)% | 309 (474) | 273 (176) | 409 (632)%% | < 0.001 |
Glucose mg/dL | 145 (64)$ | 137 (57) | 135 (69) | 129 (53) | 0.03 |
(): standard deviation.
Demographic data:.
& RSV vs. SARS: p = 0.01 (&&Influenza B vs. Influenza A: p = 0.048 / &&&SARS—CoV-2 vs. Influenza A / B: p = 0.001, respectively).
Clinical Symptoms:.
&RSV vs. SARS-CoV-2: p < 0.001 (&&SARS-CoV-2 vs. Influenza A / B: p < 0.001, respectively).
*RSV vs. Influenza B: 0.04; **RSV vs. SARS-CoV-2 < 0.001.
#RSV vs. Influenza B: p < 0.001, ##RSV vs. SARS-CoV-2: p = 0.005 (###Influemza A vs. Influenza B: p < 0.001; ####Influenza A vs. SARS-CoV-2: p = 0.001).
$RSV vs. Influenza A: < 0.001.
Laboratory parameters.
&RSV vs. Influenza A: p = 0.014 (&&Influenza A vs. Influenza B: p = 0.014 / &&&Influenza A vs. SARS-CoV-2: p = 0.010.
*RSV vs. Influenza A: p = 0.015 / ⁎⁎RSV vs. Influenza B: p < 0.001.
#RSV vs. SARS-CoV-2: p < 0.01 (##Influenza B vs. Influenza A: p = 0.016 / ###SARS-CoV-2 vs. Influenza A / B: p < 0.01, respectively).
%RSV vs. SARS-CoV-2: p < 0.01 (%%SARS vs. Influenza A / B: p < 0.01, respectively).
§RSV vs. SARS-CoV-2: p = 0.020.